The COVID-19 pandemic may impact patients with atopic dermatitis (AD) more. To assess this, a large cross-sectional study was conducted to investigate the associations between COVID-19-related impact and AD severity among adults in the Dutch general population.
Learn more at the Journal of the American Academy of Dermatology International.